Loading…
Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic‐Pharmacodynamic Modeling Approaches
Chimeric antigen receptor T cell (CAR‐T cell) therapies have shown significant efficacy in CD19+ leukemias and lymphomas. There remain many challenges and questions for improving next‐generation CAR‐T cell therapies, and mathematical modeling of CAR‐T cells may play a role in supporting further deve...
Saved in:
Published in: | Journal of clinical pharmacology 2020-10, Vol.60 (S1 Suppl 1), p.S147-S159 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Chimeric antigen receptor T cell (CAR‐T cell) therapies have shown significant efficacy in CD19+ leukemias and lymphomas. There remain many challenges and questions for improving next‐generation CAR‐T cell therapies, and mathematical modeling of CAR‐T cells may play a role in supporting further development. In this review, we introduce a mathematical modeling taxonomy for a set of relatively simple cellular kinetic‐pharmacodynamic models that describe the in vivo dynamics of CAR‐T cell and their interactions with cancer cells. We then discuss potential extensions of this model to include target binding, tumor distribution, cytokine‐release syndrome, immunophenotype differentiation, and genotypic heterogeneity. |
---|---|
ISSN: | 0091-2700 1552-4604 |
DOI: | 10.1002/jcph.1691 |